Viewing Study NCT02398461


Ignite Creation Date: 2025-12-24 @ 12:08 PM
Ignite Modification Date: 2026-01-07 @ 7:20 AM
Study NCT ID: NCT02398461
Status: COMPLETED
Last Update Posted: 2018-08-22
First Post: 2015-03-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse
Sponsor: Acorda Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module